Descarboxyl levofloxacin
CAS : 178964-53-9
Ref. 3D-FD21152
| 1mg | Arrêté | ||
| 2mg | Arrêté | ||
| 5mg | Arrêté | ||
| 10mg | Arrêté | ||
| 25mg | Arrêté |
Informations sur le produit
Nom :
Descarboxyl levofloxacin
Synonymes :
- (3S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7H-pyrido[1,2,3-de]-1,4-benzoxazin-7-one
- 7H-Pyrido[1,2,3-de]-1,4-benzoxazin-7-one, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-, (S)-
- 7H-Pyrido[1,2,3-de]-1,4-benzoxazin-7-one, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-, (3S)-
Description :
Descarboxyl levofloxacin (DLF) is a prodrug form of levofloxacin that is converted to the active form, levofloxacin, in vivo. DLF has been shown to be more stable than the free drug and it can be used as an alternative to the free drug for the treatment of bacterial infections. DLF has been shown to have good activity against methicillin-resistant Staphylococcus aureus (MRSA) and Mycobacterium tuberculosis, but not against other bacteria such as Pseudomonas aeruginosa or Escherichia coli. The major impurities of DLF are methanoic acid, elution time, n-oxide, and genotoxic impurities. The purity of DLF is determined by analytical methods such as HPLC and LC/MS. The linear range for DLF is between 0.1-10 micrograms per milliliter
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
317.36 g/mol
Formule :
C17H20FN3O2
Degré de pureté :
Min. 95%
Couleur/Forme :
Powder
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
